DRDO developed 2-DG, India's first anti-Covid drug, for saving life in the pandemic situation. But questions are being raised on 2-DG effectiveness. All India Institute Of Medical Sciences (AIIMS) director Randeep Guleria said 2-DG data needs to be expanded on more population. It will help to establish, 2-DG is effective on which Covid patient. Watch the video to know more.